A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee

NCT00944892 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee

Interventions

DRUG: REGN475
OTHER: Placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]